C2N Diagnostics partners with Cambridge Cognition in UK
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
Beacon says gene therapy succeeds in key trial of rare eye disease XLRP
Beacon Therapeutics has succeeded in a genetic eye disease where large drugmakers including Johnson & Johnson and Biogen have failed.
America's Best Outpatient Addiction Treatment Centers 2027 Survey
Newsweek and Statista are evaluating the Best Outpatient Addiction Treatment Centers in America for 2027.
World Alzheimer Day: Osun NOA urges early diagnosis
The National Orientation Agency, NOA, Osun State Directorate, has urged Nigerians to seek early diagnosis and provide support for people living with dementia as the world marks World Alzheimer’s Day…
Centre calls for review of Hospital Consumable Prices after Mundhe flags MRP gaps: Sources
The Centre has started discussion with Medical sector and private hospitals on trade margin rationalisation for medical devices, according to sources.
‘Constant bombardment’ – Fans shown 65,000 junk food ads at World Cup
Football fans were shown a “constant bombardment” of advertisements promoting junk food and drinks during matches at the 2026 Fifa World Cup, according to a new study.